➡️%age achieving ACR20 (not H2H comparisons): ⭐️GUS > IXE > TOFA > CTZ > ETN > INF > ADA > SEC > GOL > UST > APR ➡️ Choosing therapies in AxSpA: ⭐️TNFi (ADA), IL17i (SEC), Jaki (UPA); however, axPsA may be different than AxSpA. Need more trials to assess! #EULAR2021 @RheumNow https://t.co/toMyS3uPAZ